• Explore /
  • Poster
  • / NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer.

NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer.

Abstract Poster

Authors

null

Thomas Crosby

Velindre Hospital NHS Foundation Trust, Cardiff, United Kingdom

Thomas Crosby , Somnath Mukherjee , Chris Hurt , Sarah Gwynne , Simon Gollins , Andrew Rea Bateman , Wyn Griffith Lewis , Ganesh Radhakrishna , Maria Hawkins , Heike I. Grabsch , Ruby Ray , Ricky A. Sharma , Wendy Wade , Rhydian Maggs , Bethan Tranter , Ashley Roberts , Sue Hadlow , David Sebag-Montefiore , Tim Maughan , Gareth Griffiths

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01843829

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS4144)

DOI

10.1200/jco.2014.32.15_suppl.tps4144

Abstract #

TPS4144

Poster Bd #

231A

Abstract Disclosures

Similar Posters

First Author: Somnath Mukherjee

First Author: Somnath Mukherjee

First Author: Carlos Fernandez-Martos

First Author: Ji Zhu